查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613341

诊断契约製造市场：按类型、服务、应用分类 - 2025-2030 年全球预测

Diagnostic Contract Manufacturing Market by Type, Services, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年诊断契约製造市场的市场规模为286.3亿美元，预计到2024年将达到314.9亿美元，复合年增长率为10.37%，到2030年将达到571.4亿美元。

诊断契约製造是指将诊断试剂的开发和生产外包给专业的第三方製造商。该部门主要致力于医疗诊断并生产试剂、化验和分析仪器等基本组件。对诊断契约製造的需求是由对具有成本效益的解决方案不断增长的需求、对简化生产的需求以及无需昂贵的资本投资即可快速扩大营运规模的能力所推动的。应用范围广泛，包括基因检测、感染疾病诊断和个人化医疗，我们为医院、诊所和实验室等最终用户提供服务。

主要市场统计
基准年[2023] 286.3亿美元
预测年份 [2024] 314.9亿美元
预测年份 [2030] 571.4亿美元
复合年增长率（%） 10.37%

市场成长在很大程度上受到医疗保健支出增加、诊断自动化和人工智慧等技术进步以及需要高级诊断的慢性病和感染疾病增加的影响。此外，COVID-19 大流行加速了对强大诊断解决方案的需求，并进一步强调了对契约製造的需求。关键的商机在于提供多样化的分子诊断和个人化医疗解决方案，并将服务扩展到疾病盛行率高但诊断能力低的新兴市场。公司应该投资与生技公司和医疗保健提供者的合作伙伴关係，以加强产品系列和市场覆盖范围。

然而，市场面临监管要求严格、竞争激烈、智慧财产权保密等挑战。目标市场的经济限制也可能是限制因素。为了克服这些障碍，专注于数位健康诊断和远端医疗应用的创新可能会带来变革。透过投资小型化诊断设备的研发并整合物联网解决方案，公司可以吸引註重成本且精通技术的受众。市场竞争激烈，但创新时机已经成熟，动态格局需要敏捷性和策略伙伴关係，以抓住新兴机会并有效应对挑战。

市场动态：快速发展的诊断合约契约製造市场的关键市场洞察

诊断契约製造市场正在因供需的动态交互作用而发生转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 诊断公司对成本效益和优化流程的高要求
    • 提高预防医学意识并扩大诊断测试的采用
  • 市场限制因素
    • 与建立製造设施相关的高成本
  • 市场机会
    • 诊断製造过程中的技术进步
    • 开发契约製造的永续和绿色方法
  • 市场挑战
    • 确保产品品质和智慧财产权相关的风险

波特的五力战略工具驾驭诊断合约契约製造市场

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解诊断试剂契约製造市场的外部影响

外部宏观环境因素在塑造诊断契约製造市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解诊断试剂契约製造市场的竞争状况

诊断契约製造市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵诊断合约契约製造市场供应商绩效评估

FPNV定位矩阵是评估诊断契约製造市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议 绘製诊断合约契约製造市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对诊断契约製造市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 诊断公司对具有成本效益和优化流程的高需求
      • 提高预防保健意识并增加诊断测试的采用
    • 抑制因素
      • 建立生产设施的成本很高
    • 机会
      • 诊断製造流程的技术进步
      • 在契约製造中发展永续和环保的实践
    • 任务
      • 确保产品品质和智慧财产权相关的风险
  • 市场区隔分析
    • 类型：自有品牌製造服务对于进入新市场或以最少的投资增强现有产品线的需求很高。
    • 应用：更多采用诊断成像设备的诊断试剂契约製造服务
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 诊断试剂契约製造市场：按类型

  • 端对端製造
  • 个别零件製造
  • 分包劳务或服务；
  • 自有品牌製造

第七章 诊断试剂契约製造市场：依服务分类

  • 包装和组装服务
  • 产品开发及製造服务
  • 品管服务

第八章 诊断试剂契约製造市场：依应用分类

  • 影像诊断设备
  • 配方开发
  • 体外诊断设备

第九章 北美、南美诊断试剂契约製造市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太诊断契约製造市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲诊断试剂契约製造市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FUJIREBIO和 Agappe 之间的策略性业务联盟加强了诊断解决方案
    • Axim Biotechnologies 透过与 Auer Precision 合作加强检测生产
    • Almac 集团透过对卓越诊断製造的策略投资进行扩张
  • 战略分析和建议

公司名单

  • Argonaut Manufacturing Services Inc.
  • Bio-Techne Corporation
  • Celestica Inc.
  • Comar
  • Donatelle
  • EKF Diagnostics Holdings PLC
  • FlexMedical Solutions
  • Fortis Life Sciences
  • Gerresheimer AG
  • Invetech
  • Invetech Pty. Ltd.
  • Jabil Inc.
  • Keller Technology Corporation
  • KMC Systems by Elbit Systems Ltd.
  • LaunchWorks CDMO
  • Merck KGaA
  • Microcoat Biotechnologie GmbH
  • Prestige Diagnostics
  • Sanmina Corporation
  • Savyon Diagnostics
  • SCHOTT AG
  • TCS Biosciences
  • TE Connectivity Ltd.
  • TECHLAB, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-7A22CB0E649D

The Diagnostic Contract Manufacturing Market was valued at USD 28.63 billion in 2023, expected to reach USD 31.49 billion in 2024, and is projected to grow at a CAGR of 10.37%, to USD 57.14 billion by 2030.

Diagnostic Contract Manufacturing encompasses the outsourcing of diagnostic product development and production to specialized third-party manufacturers. This sector caters primarily to medical diagnostics, producing essential components like reagents, assays, and analytical instruments. The necessity for diagnostic contract manufacturing stems from the growing demand for cost-effective solutions, the need for streamlined production, and the capability to scale operations rapidly without hefty capital investments. Applications range widely, including genetic testing, infectious disease diagnostics, and personalized medicine, serving end-users such as hospitals, clinics, and laboratories.

KEY MARKET STATISTICS
Base Year [2023] USD 28.63 billion
Estimated Year [2024] USD 31.49 billion
Forecast Year [2030] USD 57.14 billion
CAGR (%) 10.37%

The market growth is largely influenced by increasing healthcare expenditure, technological advancements such as automation and AI in diagnostics, and the rise in chronic and infectious diseases necessitating advanced diagnostics. Furthermore, the COVID-19 pandemic accelerated demand for robust diagnostic solutions, further emphasizing the need for contract manufacturing. Key opportunities lie in diversifying offerings in molecular diagnostics and personalized medical solutions, as well as expanding services into emerging markets with a high prevalence of diseases but lower diagnostic capabilities. Companies should invest in partnerships with biotech firms and healthcare providers to enhance product portfolio and market reach.

However, the market faces challenges including stringent regulatory requirements, high competition, and confidentiality concerns regarding intellectual property. Economic constraints in target markets can also be a limiting factor. To overcome these hurdles, focusing on innovations in digital health diagnostics and telemedicine applications could be transformative. By investing in R&D for miniaturized diagnostic devices and integrating IoT-enabled solutions, companies can appeal to the cost-conscious and technologically savvy segments. The market is competitive, yet ripe for innovation, with a dynamic landscape demanding agility and strategic partnerships to capture burgeoning opportunities and address the challenges effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diagnostic Contract Manufacturing Market

The Diagnostic Contract Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High demand for cost-effective and optimized processes by diagnostic companies
    • Increasing awareness of preventive healthcare and growing adoption of diagnostic tests
  • Market Restraints
    • High cost associated with setting up manufacturing facility
  • Market Opportunities
    • Technological advancement in diagnostic manufacturing processes
    • Development of sustainable and green practices in contract manufacturing
  • Market Challenges
    • Risk associated with ensuring product quality and intellectual property rights

Porter's Five Forces: A Strategic Tool for Navigating the Diagnostic Contract Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diagnostic Contract Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diagnostic Contract Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diagnostic Contract Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diagnostic Contract Manufacturing Market

A detailed market share analysis in the Diagnostic Contract Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diagnostic Contract Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diagnostic Contract Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diagnostic Contract Manufacturing Market

A strategic analysis of the Diagnostic Contract Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diagnostic Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Argonaut Manufacturing Services Inc., Bio-Techne Corporation, Celestica Inc., Comar, Donatelle, EKF Diagnostics Holdings PLC, FlexMedical Solutions, Fortis Life Sciences, Gerresheimer AG, Invetech, Invetech Pty. Ltd., Jabil Inc., Keller Technology Corporation, KMC Systems by Elbit Systems Ltd., LaunchWorks CDMO, Merck KGaA, Microcoat Biotechnologie GmbH, Prestige Diagnostics, Sanmina Corporation, Savyon Diagnostics, SCHOTT AG, TCS Biosciences, TE Connectivity Ltd., TECHLAB, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Diagnostic Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across End-to-End Manufacturing, Individual Component Manufacturing, Labor or Service Subcontracting, and Private Label Manufacturing.
  • Based on Services, market is studied across Packaging & Assembly Services, Product Development & Manufacturing Services, and Quality Management Services.
  • Based on Application, market is studied across Diagnostic Imaging Devices, Formulation Development, and In Vitro Diagnostic Devices.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High demand for cost-effective and optimized processes by diagnostic companies
      • 5.1.1.2. Increasing awareness of preventive healthcare and growing adoption of diagnostic tests
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with setting up manufacturing facility
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in diagnostic manufacturing processes
      • 5.1.3.2. Development of sustainable and green practices in contract manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Risk associated with ensuring product quality and intellectual property rights
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing demand for private label manufacturing services aimed at entering new markets or augmenting existing product lines with minimal investment
    • 5.2.2. Application: Rising adoption of diagnostic contract manufacturing services for diagnostic imaging devices
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diagnostic Contract Manufacturing Market, by Type

  • 6.1. Introduction
  • 6.2. End-to-End Manufacturing
  • 6.3. Individual Component Manufacturing
  • 6.4. Labor or Service Subcontracting
  • 6.5. Private Label Manufacturing

7. Diagnostic Contract Manufacturing Market, by Services

  • 7.1. Introduction
  • 7.2. Packaging & Assembly Services
  • 7.3. Product Development & Manufacturing Services
  • 7.4. Quality Management Services

8. Diagnostic Contract Manufacturing Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Imaging Devices
  • 8.3. Formulation Development
  • 8.4. In Vitro Diagnostic Devices

9. Americas Diagnostic Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Diagnostic Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Diagnostic Contract Manufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Strategic Business Collaboration Between Fujirebio and Agappe Enhances Diagnostic Solutions
    • 12.3.2. Axim Biotechnologies Boosts Assay Production Through Auer Precision Partnership
    • 12.3.3. Expansion of Almac Group Through a Strategic Investment in Diagnostic Manufacturing Excellence
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Argonaut Manufacturing Services Inc.
  • 2. Bio-Techne Corporation
  • 3. Celestica Inc.
  • 4. Comar
  • 5. Donatelle
  • 6. EKF Diagnostics Holdings PLC
  • 7. FlexMedical Solutions
  • 8. Fortis Life Sciences
  • 9. Gerresheimer AG
  • 10. Invetech
  • 11. Invetech Pty. Ltd.
  • 12. Jabil Inc.
  • 13. Keller Technology Corporation
  • 14. KMC Systems by Elbit Systems Ltd.
  • 15. LaunchWorks CDMO
  • 16. Merck KGaA
  • 17. Microcoat Biotechnologie GmbH
  • 18. Prestige Diagnostics
  • 19. Sanmina Corporation
  • 20. Savyon Diagnostics
  • 21. SCHOTT AG
  • 22. TCS Biosciences
  • 23. TE Connectivity Ltd.
  • 24. TECHLAB, Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. DIAGNOSTIC CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DIAGNOSTIC CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIAGNOSTIC CONTRACT MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY END-TO-END MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY INDIVIDUAL COMPONENT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY LABOR OR SERVICE SUBCONTRACTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY PRIVATE LABEL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & ASSEMBLY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT DEVELOPMENT & MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY QUALITY MANAGEMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY IN VITRO DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. DIAGNOSTIC CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023